Kestra Medical Technologies, Ltd.
NASDAQ:KMTS · NASDAQ Global Select
-$0.07 today
Vol 0.37M · Avg 0.33M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:KMTS · Revenue to Net Income
Key Ratios
Analysis
$83.7M of revenue converted into -$144.8M of net income for the selected period. Gross margin is 48.3% and net margin is -180.0%, showing how much revenue survives after costs and taxes. EPS is $-3.96, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $59.8M +115.1% | $27.8M +264.5% | $7.6M | $0 | $0 | $921.6M | $731.2M | $843.2M |
| Cost of Revenue | $35.6M +29.7% | $27.5M +50.2% | $18.3M | $0 | $0 | $804.0M | $882.4M | $1.3B |
| Gross Profit | $24.2M +6587.8% | $362.0K +103.4% | -$10.7M | $0 | $0 | $7.6B | $6.2B | $4.9B |
| Gross Margin | 40.5% +39.2pp | 1.3% +140.9pp | -139.6% | — | — | 28.9% | 38.3% | 12.3% |
| Research & Development | $15.7M +1.0% | $15.5M -1.7% | $15.8M -16.2% | $18.8M -17.5% | $22.8M | $1.3B | $490.4M | $1.1B |
| Selling, General & Admin | $114.9M +64.3% | $69.9M +29.5% | $54.0M +288.5% | $13.9M +113.3% | $6.5M | $923.0M | -$1.5B | $732.6M |
| Operating Expenses | $130.6M +52.9% | $85.4M +22.4% | $69.8M +113.3% | $32.7M +11.6% | $29.3M | $7.0B | $8.7B | $7.3B |
| Depreciation & Amortization | $8.0M -31.1% | $11.6M +138.1% | $4.9M +1056.0% | $420.0K -12.1% | $478.0K | $1.2B | $631.8M | $1.5B |
| EBITDA | -$98.0M -28.4% | -$76.3M -3.5% | -$73.7M -128.1% | -$32.3M -12.1% | -$28.8M | $6.8B | $9.3B | $11.9B |
| EBITDA Margin | -163.8% +110.5pp | -274.3% +692.1pp | -966.4% | — | — | 46.3% | 42.0% | 37.7% |
| Operating Income | -$106.4M -25.1% | -$85.1M -5.8% | -$80.4M -145.9% | -$32.7M -11.6% | -$29.3M | $14.0B | -$15.7B | $14.3B |
| Operating Margin | -177.8% +128.0pp | -305.8% +748.2pp | -1054.0% | — | — | 24.1% | 22.0% | 29.5% |
| Interest Income | $3.2M | $0 | $0 | $0 | $0 | -$1.6B | $405.0M | $561.8M |
| Interest Expense | $7.7M +24.1% | $6.2M +10.7% | $5.6M +381.9% | $1.2M | $0 | $1.0B | $1.2B | $1.3B |
| Other Income / Expenses | -$7.3M +19.2% | -$9.0M -137.6% | -$3.8M -215.3% | -$1.2M | $0 | $1.4B | $1.2B | $1.1B |
| Income Before Tax | -$113.7M -20.8% | -$94.1M -11.7% | -$84.2M -148.3% | -$33.9M -15.7% | -$29.3M | $4.9B | $3.6B | $5.3B |
| Pre-Tax Margin | -190.1% +148.3pp | -338.3% +765.5pp | -1103.8% | — | — | 18.7% | 26.2% | 24.1% |
| Income Tax Expense | $135.0K +462.5% | $24.0K +60.0% | $15.0K -92.0% | $187.0K +26.4% | $148.0K | -$1.6B | $745.2M | $1.0B |
| Net Income | -$113.8M -20.9% | -$94.1M -11.7% | -$84.2M -147.0% | -$34.1M -15.7% | -$29.5M | $4.8B | $4.7B | -$15.5B |
| Net Margin | -190.3% +148.1pp | -338.4% +765.6pp | -1104.0% | — | — | 17.5% | 22.5% | 27.5% |
| EPS (Basic) | -$5 -151.5% | -$2 -16.6% | -$2 -153.6% | -$1 -16.9% | -$1 | $703.2M | $1.3B | $512.8M |
| EPS (Diluted) | -$5 -151.5% | -$2 -16.6% | -$2 -153.6% | -$1 -16.9% | -$1 | $609.4M | $452.6M | $598.2M |
| Weighted Avg Shares | $49.5M +0.0% | $49.5M +0.0% | $49.5M +0.0% | $49.5M +0.0% | $49.5M | $925.8M | $1.1B | $1.3B |
| Weighted Avg Shares (Diluted) | $49.5M +0.0% | $49.5M +0.0% | $49.5M +0.0% | $49.5M +0.0% | $49.5M | $924.4M | $678.0M | -$1.5B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Neogen Corporation
NASDAQ:NEOG
$1.97B
Pulse Biosciences, Inc.
NASDAQ:PLSE
$1.80B
NovoCure Limited
NASDAQ:NVCR
$1.71B
STAAR Surgical Company
NASDAQ:STAA
$1.42B
Precigen, Inc.
NASDAQ:PGEN
$1.39B
BioLife Solutions, Inc.
NASDAQ:BLFS
$1.27B
Wave Life Sciences Ltd.
NASDAQ:WVE
$1.16B
Azenta, Inc.
NASDAQ:AZTA
$1.05B
Evotec SE
NASDAQ:EVO
$921.71M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does KMTS generate?
Kestra Medical Technologies, Ltd. (KMTS) reported $59.81M of revenue in fiscal 2025.
Is KMTS profitable?
Kestra Medical Technologies, Ltd. (KMTS) reported -$113,814,000.00 of net income, with a net margin of -190.3%.
Explore More
Continue the stock analysis
Jump to another research area for this company.